2019³â Ãá°èÇмú´ëȸ ¹× ¿¬¼ö°Á´ 3¿ù 8Àϰú 9ÀÏ ¾çÀÏ¿¡ °ÉÃÄ ´ëÀü ÄÁº¥¼Ç ¼¾ÅÍ¿¡¼ °³ÃֵǾú´Ù.
ÀÌ¿¡ ¾Õ¼ 3¿ù 8ÀÏ ±Ý¿äÀÏ ¿ÀÀü¿¡ °©»ó¼± ÃÊÀ½ÆÄ hands-on course °¡ ÀÖ¾î °©»ó¼± ÃÊÀ½ÆÄ °ÀÇ ¹× ½ÇÀü ¿¬½ÀÀ» ÇÒ ¼ö ÀÖ´Â ½Ã°£ÀÌ ¸¶·ÃµÇ¾î Å« È£ÀÀÀ» ¾ò¾ú´Ù.
symposiumÀº Å©°Ô up to date treatment of anaplastic thyroid cancer, New WHO classification¿¡¼ ¸»ÇÏ´Â Borderline Thyroid tumor¸¦ ¾î¶»°Ô ¹Þ¾ÆµéÀÏ °ÍÀΰ¡?, Novel insight into thyroid hormone, °£È£»ç session, Diagnosing strategy of thyroid nodules, ±¹¹Î°Ç°º¸Çè °ø´ÜÀÚ·á ºÐ¼®À¸·Î ³ª´µ¾î ÁøÇàµÇ¾ú´Ù.
ƯÈ÷ ÀÌÁß new WHO classification °ú °ü·ÃÇÏ¿© »õ·Ó°Ô Á¤ÀÇµÈ borderline thyroid tumor ÀÇ ºÐ·ù¿Í Á¤ÀÇ, ÀÌ¿¡ ÀÇÇÑ º´¸®º¸°í ¹× Áø´ÜÀÇ º¯È µî¿¡ ´ëÇØ º´¸®°ú Á¤Âù±Ç ±³¼ö´ÔÀÇ °Àǰ¡ ÀÖ¾ú´Ù. ¶ÇÇÑ º¯ÈµÈ Á¤ÀÇ¿¡ µû¸¥ ¼ö¼úÀû Ä¡·á¿¡ ´ëÇØ Á¤±â¿í±³¼ö´ÔÀÇ °ÀÇ ÈÄ case discussionÀ¸·Î ȸ¿øµé¿¡°Ô »õ·Î¿î Á¤º¸¸¦ Àü´ÞÇϰí À̸¦ ÅëÇØ borderline thyroid tumor ¶ó´Â »õ·Î¿î Áúº´ Ä«Å×°í¸®¿¡ ÀûÀÀÇÏ´Â ½Ã°£À» °¡Á³´Ù.
meet the professor session¿¡¼´Â ³ªµ¿±Ô ±³¼ö´ÔÀÌ °©»ó¼± °áÀýÀÇ ÃÊÀ½ÆÄ °Ë»çÀÇ °ú°Å, ÇöÀç, ¹Ì·¡¿¡ ´ëÇØ °ÀǸ¦ ÁøÇàÇØ ÁÖ¾úÀ¸¸ç, thyroid gland development¿¡ °üÇØ stem cell ¿¡¼ °©»ó¼±ÀÇ ±â´ÉÀ» ³ªÅ¸³»±â±îÁöÀÇ ºÐÈ ¹× ¹ß´Þ °úÁ¤À» Weill Cornell Medical College ÀÇ Dr. Anthony N. Hollenberg±³¼ö°¡ °ÀÇÇØ ÁÖ¾ú´Ù. ¶ÇÇÑ Dr. Anthony N. Hollenberg±³¼ö´Â plenary lecture¿¡¼ Thyroid hormone action ¿¡ ´ëÇÑ »õ·Î¿î ³»¿ëÀ» °ÀÇÇÏ¿© ȸ¿øµé°ú °øÀ¯ÇÒ ¼ö ÀÖ´Â ±âȸ°¡ µÇ¾ú´Ù.
º» ÇÐȸÀÇ °¡Àå ÀÇ¹Ì ÀÖ´Â »óÀ̶ó°í ÇÒ ¼ö ÀÖ´Â ¹ü»êÇмú»ó ¼ö»ó ±â³ä °ÀÇ·Î´Â ÃæºÏÀÇ´ë ³»°ú ±Ã¼º¼ö ±³¼ö´Ô²²¼ Antithyroid Drug¿Í °ü·ÃµÈ °æÇè ¹× ÃֽŠÁö°ß¿¡ ´ëÇÑ ³»¿ëÀ» °ÀÇÇÏ¿© dzºÎÇÑ °æÇèÀ» °øÀ¯ÇÒ ¼ö ÀÖ´Â ±âȸ°¡ µÇ¾ú´Ù.
¿¬±¸À§¿øÈ¸¿¡¼´Â °©»ó¼± ¾ÏÀÌ ¾Æ´Ñ ´Ù¸¥ ¾Ï¿¡¼ÀÇ BRAF somatic mutation ¿¡ ´ëÇÑ »õ·Î¿î ¿¬±¸µéÀ» ÁÖÁ¦·Î ÇâÈÄ °©»ó¼±ÇÐ ¿¬±¸¿¡ ÀÖ¾î »õ·Î¿î Á¢±Ù¹æ¹ý¿¡ ´ëÇÑ »ý°¢À» °øÀ¯ÇÒ ¼ö ÀÖ´Â ½Ã°£ÀÌ µÇ¾î °©»ó¼±ÇÐÀÇ ¿¬±¸¿¡ °ü½ÉÀÖ´Â ¿¬±¸Àڵ鿡°Ô Å« µµ¿òÀÌ µÈ °ÍÀ¸·Î »ý°¢µÇ¾ú´Ù.
°©»ó¼± ÇÐȸ ÀÓ»ó ¿¬±¸»óÀ¸·Î´Â ÇÐȸ Áß½ÉÀÇ ´Ù±â°ü Àӻ󿬱¸¸¦ ¸ðÁýÇÏ¿´À¸¸ç, Ãæ³²ÀÇ´ë À̺ñÀÎÈİú ±¸º»¼® ±³¼ö°¡ ¡°°©»ó¼±À¯µÎ¾Ï ȯÀÚ¿¡¼ lobectomy ÈÄ TSH suppression ÀÇ ÀÓ»óÀû À¯¿ë¼º¡±, ºÎ»êÀÇ´ë ³»°ú ±èº¸Çö ±³¼ö°¡ ¡°Clinical characteristics and prognosis of rare variants of papillary thyroid carcinoma¡±, Ãæ³²ÀÇ´ë À̺ñÀÎÈİú ÀåÀç¿ø ±³¼ö°¡ ¡°Multicenter retrospective cohort study for deciding the optimal surgical extent in 1~4cm sized differentiated thyroid carcinoma¡± ±×¸®°í ¾ÆÁÖÀÇ´ë ¿µ»óÀÇÇаú ÇÏÀºÁÖ ±³¼ö°¡ ¡°US differentiation of follicular-patterned tumor: multicenter retrospective cohort study¡± °¡ ¼öÁÖ ÇÏ¿´´Ù.
ÇÐȸ ÈÄ ÁøÇàµÈ ¿¬¼ö°Á¿¡µµ 123¸íÀÌ Âü¼®ÇÏ¿© °©»ó¼± ±â´ÉÀÌ»óÀÇ Áø´Ü°ú Ä¡·á ¹× °©»ó¼± °áÀý°ú ¾ÏÀ̶ó´Â ÁÖÁ¦·Î °©»ó¼± Áø·á¿¡ ÀÖ¾î ÀüüÀûÀÎ È帧°ú ÃֽŠÁö°ßÀ» Á¢ÇÒ ¼ö ÀÖ´Â ½Ã°£ÀÌ µÇ¾ú´Ù.